Table I.
Gene mutational profile in a patient with lung adenocarcinoma by next-generation sequencing of DNA obtained from surgical specimens.
Genes | Mutation sites | Frequency, % | Amplification (copy no.) |
---|---|---|---|
HER2 | F616La | 1.46 | 11 |
ErbB4 | N280I | 24.41 | |
GATA1 | S12P | 1.17 | |
GNAS | T386P | 1.82 | |
KIT | M1R | 2.58 | |
KIT | A621S | 21.79 | |
MSH3 | K281fs | 1.73 | |
TP53 | G154V | 33.57 | |
VEGFA | L139R | 1.08 |
aThis mutation is not a classic activating mutation and unlikely to be responsible for the responsiveness to HER2-targeted therapy.